GlassScriptPhysician profile
Naderge P Pierre
NPI 1770804619
$1,659.91
in general payments reported to CMS, 2019-2025
9 companies · $317 in 2025
The $317 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $181 · 2022: $464 · 2023: $116 · 2024: $582 · 2025: $317.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,015.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,015.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $765.91 | 2022-2025 | Interstim, Infinity Occipitocervical Upper Thoracic System |
| Intuitive Surgical, INC. | $509.11 | 2020-2025 | Da Vinci Surgical System |
| Stryker Corporation | $123.60 | 2024-2025 | 1788, Spy-Phi System |
| Ethicon US, LLC | $102.44 | 2022-2024 | Echelon; Endopath, Stratafix, Surgicel Nu-Knit |
| Supreme Orthopedic Systems, LLC | $47.46 | 2025 | |
| Axonics, INC. | $41.14 | 2024 | Axonics |
| Olympus America INC. | $31.64 | 2024 | Olympus, Olympus, Evis Exera III Colonovideoscope |
| Boston Scientific Corporation | $30.56 | 2025 | Axonics |
| Heron Therapeutics, INC. | $8.05 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Naderge Pierre listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.